GB0210538D0 - Lipids and gene delivery - Google Patents

Lipids and gene delivery

Info

Publication number
GB0210538D0
GB0210538D0 GBGB0210538.5A GB0210538A GB0210538D0 GB 0210538 D0 GB0210538 D0 GB 0210538D0 GB 0210538 A GB0210538 A GB 0210538A GB 0210538 D0 GB0210538 D0 GB 0210538D0
Authority
GB
United Kingdom
Prior art keywords
lipids
gene delivery
gene
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0210538.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Priority to GBGB0210538.5A priority Critical patent/GB0210538D0/en
Publication of GB0210538D0 publication Critical patent/GB0210538D0/en
Priority to AU2003240997A priority patent/AU2003240997A1/en
Priority to PCT/GB2003/001985 priority patent/WO2003094974A1/en
Priority to EP03730315A priority patent/EP1506019A1/en
Priority to JP2004503057A priority patent/JP2005530771A/ja
Priority to US10/983,464 priority patent/US7598421B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0210538.5A 2002-05-08 2002-05-08 Lipids and gene delivery Ceased GB0210538D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0210538.5A GB0210538D0 (en) 2002-05-08 2002-05-08 Lipids and gene delivery
AU2003240997A AU2003240997A1 (en) 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells
PCT/GB2003/001985 WO2003094974A1 (en) 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells
EP03730315A EP1506019A1 (en) 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells
JP2004503057A JP2005530771A (ja) 2002-05-08 2003-05-08 生物学的活性物質の細胞への運搬に適した複合体
US10/983,464 US7598421B2 (en) 2002-05-08 2004-11-08 Materials for the delivery of biologically-active material to cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0210538.5A GB0210538D0 (en) 2002-05-08 2002-05-08 Lipids and gene delivery

Publications (1)

Publication Number Publication Date
GB0210538D0 true GB0210538D0 (en) 2002-06-19

Family

ID=9936285

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0210538.5A Ceased GB0210538D0 (en) 2002-05-08 2002-05-08 Lipids and gene delivery

Country Status (5)

Country Link
EP (1) EP1506019A1 (enExample)
JP (1) JP2005530771A (enExample)
AU (1) AU2003240997A1 (enExample)
GB (1) GB0210538D0 (enExample)
WO (1) WO2003094974A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313132D0 (en) 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
WO2005117985A2 (en) * 2004-06-02 2005-12-15 Ucl Biomedica Plc Lipopolyplex construct with an integrin binding peptide for delivery of nucleic acids, peptides or drugs
DK2355851T3 (en) 2008-11-10 2018-06-25 Arbutus Biopharma Corp Newly known lipids and compositions for release of therapeutic agents
EP4207205A4 (en) * 2020-08-31 2025-02-26 Takeda Pharmaceutical Company Limited Inference device, inference method, inference program, model generating method, inference service providing system, inference service providing method, and inference service providing program

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
ES2299232T3 (es) * 1995-09-11 2008-05-16 La Jolla Cancer Research Foundation Moleculas que migran hacia un organo o tejido seleccionado in vivo.
US5869715A (en) * 1995-09-27 1999-02-09 The Reagents Of The University Of California Polyfunctional cationic cytofectins
AU7078396A (en) * 1995-09-27 1997-04-30 Regents Of The University Of California, The Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
GB9711115D0 (en) * 1997-05-29 1997-07-23 Inst Of Child Health Integrin-targeting vectors having enhanced transfection activity
JP4800485B2 (ja) * 1999-03-26 2011-10-26 バイカル インコーポレイテッド ポリヌクレオチドベースのワクチンに対する免疫応答を増強するためのアジュバント組成物および方法
CA2375727C (en) * 1999-05-28 2010-05-25 Vical Incorporated Cytofectin dimers and methods of use thereof

Also Published As

Publication number Publication date
EP1506019A1 (en) 2005-02-16
WO2003094974A1 (en) 2003-11-20
AU2003240997A1 (en) 2003-11-11
JP2005530771A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
AU2003286819A8 (en) Alternate delivery location methods and systems
GB2429924B (en) Delivery devices
EP1573463A3 (en) Alternate delivery location methods and systems
ZA200408199B (en) Probiotic delivery system
EP1680008A4 (en) DEVICES AND METHODS FOR FIXED-POSITION STENT INSTALLATION
AU2003290524A8 (en) Nanoparticle delivery system
AU2003210497A8 (en) Gene delivery system and methods of use
GB0012997D0 (en) Gene delivery
GB0324728D0 (en) Targeted delivery
GB0428391D0 (en) Connection and connection part
GB0210325D0 (en) Secure data delivery
AU2002365188A8 (en) Nucleic acid delivery and expression
GB0327384D0 (en) Gene therapy
EG24425A (en) Drug delivery assembly
GB2394878B (en) Hooklink and lead discharge system
GB0210538D0 (en) Lipids and gene delivery
AU2003237894A1 (en) Liposome drug delivery
AU2003296961A8 (en) Targeted invitation delivery
AU2003221673A8 (en) Pizza advertising and delivery beacon
EP1644476A4 (en) NOVEL PHYTASE AND GEN
EP1559330A4 (en) SUSHIS MANUFACTURING AND DISTRIBUTION SYSTEM
EP1696886A4 (en) METHODS AND COMPOSITIONS FOR DELIVERY OF DRUGS
AU2003294705A8 (en) Ntsm gene
GB0327814D0 (en) Aerosolisable composition and delivery system
EP1653953A4 (en) METHOD AND DEVICES FOR THE MEDICINAL PRODUCTION

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)